Comparing musculoskeletal and connective tissue disorder risks of teriparatide and abaloparatide in osteoporosis: an analysis based on FDA adverse event reporting system (FAERS)

Ming‐Tao Wen(Shandong University of Traditional Chinese Medicine), Gang Li(Shandong University of Traditional Chinese Medicine), Peixue Ling(Shandong University), Jiacheng Li(Children's Hospital of Chongqing Medical University), Bo‐Wen Lu(Shandong University of Traditional Chinese Medicine), Di Luo(Shandong University of Traditional Chinese Medicine), Fei Liu(Agricultural Genomics Institute at Shenzhen)
Expert Opinion on Drug Safety
July 17, 2024
Cited by 6


Related Papers